CompoAtlas

Sabalia

Natural health product licensed in Canada

Licence holder
Boiron Canada Inc.
NPN or DIN-HM
80017078
Status
Inactive licence
Licence date
25 March 2010
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Histaminum hydrochloricum

Source : Dichlorhydrate d'histamine

12 DHNot calculated
Ambrosia artemisiaefolia

Source : Plante entière

6 DHNot calculated
Solidago virgaurea

Source : Bourgeon floral

6 DHNot calculated
Euphrasia officinalis

Source : Plante entière

6 DHNot calculated

Non-medicinal ingredients

gomme acacia, Sucrose, Talc, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimémaximum: 6 Tous les jours
Enfantsmaximum: 2 years1 Comprimémaximum: 6 Tous les jours

Uses authorised in Canada

Médicament homéopathique utilisé pour soulager les symptômes dûs aux allergies saisonnières (rhume des foins, pollen) et environnementales (poussières, moisissures, poils d'animaux), tels que: éternuement, écoulement nasal, lamoiement, démangeaisons des yeux et picotement de la gorge.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80017078

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line